• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0030247309
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Unspecified Heart Problem (4454)
Event Date 12/04/2023
Event Type  Death  
Event Description
It was reported that the patient died.The patient presented with co-morbidities of extremely calcified vessels.The lesion being treated was the left anterior descending (lad) artery.An opticross intravascular ultrasound (ivus) imaging was utilized to ensure the correct sizing and strategy in approaching treatment of the lesion.Following orbital atherectomy to prepare the severely calcified vessel, ivus imaging was performed followed by a 10mm x 2.5mm wolverine cutting balloon catheter to further prepare the vessel prior stenting the lad.A 3.00 x 24mm and a 2.50 x 28mm synergy xd drug-eluting stents were deployed in the proximal and mid lad successfully.Post-dilatation was then performed using a 3.00mm x 15mm and a 2.50mm x 12mm nc emerge balloon catheters.After a second run of ivus imaging and confirmation of stent expansion, the procedure was deemed successfully completed.After the procedure, the patient status was initially good, and the patient was taken back to the recovery ward.However, 15 minutes later, the patient's health declined and was brought back to the procedure room to investigate the cause.An attempt to re-wire the original lesion was unsuccessful as the patient health continued to decline.The patient crashed and cardiopulmonary resuscitation (cpr) was performed, however unsuccessful, and the patient passed away.The official cause of death was post-procedural complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18387773
MDR Text Key331265082
Report Number2124215-2023-69614
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number0030247309
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient SexFemale
-
-